Ricursive Intelligence | $300,000,000 | (Jan 28, 2026)
Nerd Apply | $3,200,000 | (Jan 28, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)
Cullgen Inc.
United States
- San Diego, California
- 09/05/2023
- Unknown
- $40,000,000
Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Our technology, which we call uSMITE™ (ubiquitin-mediated, small molecule-induced target elimination) has the potential to address a broad range of intracellular disease targets, including those representing the up to 80% of proteins that cannot be addressed by existing small molecule therapies, commonly referred to as undruggable targets. In addition to using our uSMITE™ platform to build our own pipeline of protein degradation product candidates, we are also developing a portfolio of novel E3 ligands. You can learn more information about Cullgen on our website: www.Cullgen.com
- Industry Biotechnology Research
- Website https://www.cullgen.com/
- LinkedIn https://www.linkedin.com/company/cullgen/
Jelou AI | $10,000,000 | (Jan 28, 2026)
Concourse | $12,000,000 | (Jan 28, 2026)
Risotto | $10,000,000 | (Jan 28, 2026)
Summize | $50,000,000 | (Jan 28, 2026)
FLORA(US) | $42,000,000 | (Jan 28, 2026)
Fortitude Biomedicines | $13,000,000 | (Jan 28, 2026)
Chamelio | $10,000,000 | (Jan 28, 2026)
Opendate | $14,000,000 | (Jan 28, 2026)
Memcyco | $37,000,000 | (Jan 28, 2026)
Midship | $4,150,000 | (Jan 28, 2026)